Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Modelling Bloodstream Infection Patient Outcomes Using Bacterial Biochemical Factors and Machine Learning

EF 2022-23

Résumé
When deciding how to treat a bloodstream infection (BSI), doctors perform standard diagnostic tests to determine (1) the identity of the bacteria causing the infection and (2) which antibiotics the infection resists. A major problem with these standard tests is that they can take days to perform. Meanwhile, each hour that an BSI patient goes untreated substantially increases their odds of dying. A faster diagnostic tool for infections has the potential to spare tens of thousands of BSI patients each year. A diagnostic tool that measures an infection’s molecular properties (such as proteins and DNA) could be an effective alternative to standard BSI tests. This molecular data can be collected within hours and would help doctors make quicker treatment decisions, which would ultimately save BSI patient lives. The reason such a device is not currently used is that we do not know how the molecular properties of infections are related to BSI severity. I propose to investigate the relationship between bacterial molecular factors and BSI patient outcome using advanced computational tools such as machine learning. A large molecular infection dataset has been collected for this purpose since 2006, and it will allow us to map the molecular properties that are responsible for more severe infection in the most common BSI types. The molecular-to-severity map will enable the development of new, molecular-based diagnostic tools that would speed up BSI diagnosis from the order of days to hours, ultimately saving tens of thousands of lives annually. Through direct collaboration with the Alberta Centre for Advanced Diagnostics, the results produced will be immediately translated into the proposed life-saving tools.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486450
Name
Gilliland Rory
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Modelling Bloodstream Infection Patient Outcomes Using Bacterial Biochemical Factors and Machine Learning
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bloodstream Infections; Diagnostic Tool; Genomics; Machine Learning; Metabolomics; Precision Medicine; Proteomics
Abstract
When deciding how to treat a bloodstream infection (BSI), doctors perform standard diagnostic tests to determine (1) the identity of the bacteria causing the infection and (2) which antibiotics the infection resists. A major problem with these standard tests is that they can take days to perform. Meanwhile, each hour that an BSI patient goes untreated substantially increases their odds of dying. A faster diagnostic tool for infections has the potential to spare tens of thousands of BSI patients each year. A diagnostic tool that measures an infection’s molecular properties (such as proteins and DNA) could be an effective alternative to standard BSI tests. This molecular data can be collected within hours and would help doctors make quicker treatment decisions, which would ultimately save BSI patient lives. The reason such a device is not currently used is that we do not know how the molecular properties of infections are related to BSI severity. I propose to investigate the relationship between bacterial molecular factors and BSI patient outcome using advanced computational tools such as machine learning. A large molecular infection dataset has been collected for this purpose since 2006, and it will allow us to map the molecular properties that are responsible for more severe infection in the most common BSI types. The molecular-to-severity map will enable the development of new, molecular-based diagnostic tools that would speed up BSI diagnosis from the order of days to hours, ultimately saving tens of thousands of lives annually. Through direct collaboration with the Alberta Centre for Advanced Diagnostics, the results produced will be immediately translated into the proposed life-saving tools.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gilliland, Rory
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~